Avidity Biosciences
RNA
#1877
Rank
HK$85.42 B
Marketcap
HK$566.97
Share price
0.00%
Change (1 day)
120.88%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: HK$85.42 Billion

As of February 2026 Avidity Biosciences has a market cap of HK$85.42 Billion. This makes Avidity Biosciences the world's 1877th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$85.42 B1.02%
2025HK$84.56 B203.2%
2024HK$27.88 B398.36%
2023HK$5.59 B-51.43%
2022HK$11.52 B32.57%
2021HK$8.69 B17.08%
2020HK$7.42 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Avidity Biosciences was reported to be:

HK$85.42 Billion
by Nasdaq info icon info icon
HK$85.42 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
HK$1.174 T 1,274.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$814.75 B 853.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
HK$16.65 B-80.51%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
HK$47.37 B-44.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$1.07 B-98.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
HK$6.41 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
HK$85.40 B-0.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
HK$23.33 B-72.68%๐Ÿ‡บ๐Ÿ‡ธ USA